The UK is launching a vaccine to prevent gonorrhoea, targeting high-risk individuals through the National Health Service. The vaccine, originally for meningococcal disease, shows 32.7% to 42% effectiveness against gonorrhoea but is not yet approved for this use. Despite rising gonorrhoea cases in Europe, other countries are not considering its authorization. The vaccine aims to combat the surge of STIs, particularly among gay and bisexual men. Teljes cikk (Euronews.com)